Once-a-week or every-other-day urethra-sparing prostate cancer stereotactic body radiotherapy, a randomized phase II trial: 18 months follow-up results.


Zilli T., Jorcano S., Bral S., Rubio C., Bruynzeel A., Oliveira A., et al.

Cancer medicine, 2020 (SCI Expanded İndekslerine Giren Dergi)

  • Cilt numarası:
  • Basım Tarihi: 2020
  • Doi Numarası: 10.1002/cam4.2966
  • Dergi Adı: Cancer medicine